Andrx Hires Robert J. Brown to Focus on Business Development Opportunities.

Business Editors

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Nov. 11, 2002

Andrx Corporation (Nasdaq:ADRX) today announced that Robert J. Brown has joined its management team as Senior Vice President, Corporate Development, reporting directly to Richard J. Lane, Andrx's Chief Executive Officer. Mr. Brown is a fifteen-year veteran of Bristol-Myers Squibb Company where he held a series of progressively responsible positions, most recently Vice President of Corporate Development. He is assuming a newly created position at Andrx with responsibility for identifying acquisition and merger candidates as well as potential product and technology investments.

Commenting on the appointment, Mr. Lane, said: "I am pleased to welcome Bob to Andrx's management team. Having worked with him previously, I know his capabilities first-hand. He is a talented, well-connected professional who will be the catalyst we need at Andrx to focus and fully charge our business development efforts."

Mr. Brown has more than 25 years of pharmaceutical industry experience. In his positions at Bristol-Myers Squibb, his transaction experience included asset and whole business acquisitions and divestitures, joint ventures, strategic alliances, co-promotions, equity investments, and one-way and cross licensing agreements. Previously, he worked at AstraZeneca Company for five years as a pharmaceutical licensing manager/management training candidate and Smith Kline Beecham for six years where he served as a pharmaceutical chemist. Mr. Brown is a graduate of the Pennsylvania State University where he earned a B.S. in chemistry. He also holds an MBA in Finance.

About Andrx

Andrx Corporation is a specialty pharmaceutical company engaged in the formulation and commercialization of oral controlled-release generic and brand pharmaceuticals utilizing its proprietary drug delivery technologies. Andrx also markets and distributes pharmaceutical products manufactured by third parties. This release and additional information about Andrx Corporation are also available on the Internet at: http://www.andrx.com.

Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "expect," "plan," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative or other variations thereof or comparable terminology is intended to identify forward-looking statements. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including but not limited to, the Company's ability to retain executive management as described herein and Andrx's results of operations. The Company is also subject to other risks as detailed from time-to-time in the Company's filings with the Securities and Exchange Commission.